![Chemical structure of (6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione, CAS 67-73-2](https://api.angenesci.com/structure/2196/67-73-2.png)
无数据
无数据
无数据
| CAS Number | 67-73-2 |
| Catalog Number | AG0034XJ(AGN-PC-0TPY1H) |
| Chemical Name | (6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione |
| EC Number | 200-668-5 |
| IUPAC Name | (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| InChI | InChI=1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1 |
| InChI Key | FEBLZLNTKCEFIT-VSXGLTOVSA-N |
| MDL Number | MFCD00010525 |
| Molecular Formula | C24H30F2O6 |
| Molecular Weight | 452.4882 |
| NSC Number | 92339 |
| SMILES | C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])C[C@H](F)C5=CC(C=C[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O |
| UNII | 0CD5FD6S2M |
| Synonyms | Acetonide, Fluocinolone,
Acetonide, Fluortriamcinolone,
Alvadermo,
Capex,
Co Fluocin,
Co-Fluocin,
Cortiespec,
Derma Smooth FS,
Derma-Smooth FS,
Flucinar,
Fluocid,
Fluocinolone Acetonide,
Fluodermo,
Fluonid,
Fluortriamcinolone Acetonide,
Fluotrex,
Flurosyn,
Flusolgen,
Gelidina,
Jellin,
Jellisoft,
Synalar,
Synalar HP,
Synalar-HP,
Synamol,
Synemol,
FLUOCINOLONE ACETONIDE,
67-73-2,
Synalar,
Flucinar,
Synandone,
Fluonid,
Jellin,
Synamol,
Synemol,
Coriphate,
Fluovitif,
Flupollon,
Percutina,
Synandrone,
Dermalar,
Localyn,
Omniderm,
Radiocin,
Sinalar,
Synotic,
Tefunote,
Synsac,
Fluotrex,
Synalar-HP,
Retisert,
Fluocet,
Localyn Syntex,
Derma-smoothe/fs,
Cortiplastol,
Prodermin,
Fluocinolonacetonidum,
Flucort,
Fluocinolone 16,17-acetonide,
Iluvien,
Capex,
Neo-Synalar,
Fs Shampoo,
Fluocinoloni acetonidum,
Acetonide de fluocinolone,
6alpha-Fluorotriamcinolone acetonide,
Dermatin (steroid),
Fluocinolone acetonide [DCIT],
flucinolone,
RS-1401 AT,
Fluocinoloni acetonidum [INN-Latin],
component of Neo-Synalar,
Fluocinolone (Acetonide),
RS 1401AT,
C24H30F2O6,
Flucort-N,
UNII-0CD5FD6S2M,
6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide,
Acetonide de fluocinolone [INN-French],
CCRIS 3250,
Acetonida de fluocinolona [INN-Spanish],
HSDB 3083,
acetonido de fluocinolona,
EINECS 200-668-5,
MFCD00010525,
NSC 92339,
0CD5FD6S2M,
MLS000028545,
CHEBI:31623,
Fluocinolone acetonide (Flucort-N),
6-alpha,9-alpha-Difluoro-16-alpha-hydroxyprednisolone 16,17-acetonide,
NSC92339,
NSC-92339,
6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-,
Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone,
SMR000058329,
DSSTox_CID_20674,
DSSTox_RID_79533,
DSSTox_GSID_40674,
Medidur,
Acetonida de fluocinolona,
6.alpha.-Fluorotriamcinolone acetonide,
Fluortriamcinolone Acetonide,
CAS-67-73-2,
Retisert (TN),
Fluocet (TN),
Synalar (TN),
6.Alpha.,9-Difluoro,
Fluocinolone acetonide [USAN:INN:JAN],
Fluzon [Steroid],
NCGC00021301-04,
4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one,
Fluocinolon acetonid,
Fluocinoloneacetonide,
6a,9a-difluoro-16a-hydroxyprednisolone 16,17-acetonide,
Fluocinolone acetonide intravitreal implant,
AC1Q6ACL,
6.alpha.,17-acetonide,
Opera_ID_1295,
F0657,
Fluocinolone acetonide [USAN:USP:INN:JAN],
CHEMBL989,
AC1L1M1L,
SCHEMBL4795,
6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-Acetonide,
MLS001076276,
ARONIS24561,
GTPL7077,
DTXSID0040674,
EBD4852,
FEBLZLNTKCEFIT-VSXGLTOVSA-N,
Fluocinolone acetonide(Flucort-N),
Fluocinolone-acetonide(Flucort-N),
HMS2090I14,
HMS2230D13,
HMS3259G12,
HMS3715J11,
HY-B0415,
ZINC3977981,
Tox21_110869,
Tox21_302364,
AC-429,
s2470,
AKOS015963144,
Tox21_110869_1,
ACN-043362,
CCG-221165,
CS-2519,
DB00591,
NC00562,
RL04590,
6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione,
Fluocinolone acetonide (JP17/USP/INN),
NCGC00021301-06,
NCGC00255654-01,
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one,
AS-13690,
BC214761,
CC-28473,
NCI60_042042,
Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone (8CI),
Fluocinolone acetonide, analytical standard,
AB1010906,
LS-118443,
D01825,
J10113,
AB00383017-10,
AB00383017_11,
010F525,
C-22503,
SR-01000000109,
2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one,
SR-01000000109-2,
W-104704,
BRD-K94353609-001-21-6,
difluoro-hydroxy-(2-hydroxyacetyl)-tetramethyl-[?]one,
6.alpha., 9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide,
Fluocinolone acetonide, European Pharmacopoeia (EP) Reference Standard,
Fluocinolone acetonide, United States Pharmacopeia (USP) Reference Standard,
Fluocinolone acetonide for system suitability, European Pharmacopoeia (EP) Reference Standard,
Fluocinolone Acetonide, Pharmaceutical Secondary Standard; Certified Reference Material,
WLN: T F5 E5 B666 GO IO RV AHTTTT&J A BF CQ E FVIQ H H OF -A&BHO -B&ACEF,
(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosa-14,17-dien-16-one,
(2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[,
(2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one,
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one,
(6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione,
6.alpha.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,
6|A,9|A-Difluoro-11|A,16|A,17|A,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide,
6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha-17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione;,
Fluocinolone acetonide for peak identification, European Pharmacopoeia (EP) Reference Standard,
Pregna-1,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-,
Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)-, (6.alpha.,11.beta.,16.alpha.)-,
Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-,
Pregna-1,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone,
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6-alpha,11-beta,16-alpha)-,
Fluzon,
fluocinolone,
Cortiespec,
Alvadermo,
Fluodermo,
Flurosyn,
Flusolgen,
Gelidina,
Jellisoft,
Fluocid,
Mixture Name,
Co Fluocin,
Co-Fluocin,
Synalar HP,
Tri-Luma,
Derma Smooth FS,
Derma-Smooth FS,
Fluocinolonacetonid,
Flucort-N (TN),
Acetonide, Fluocinolone,
fluocinolone acetonide oil,
D02QJH,
Acetonide, Fluortriamcinolone,
fluocinolone acetonide dihydrate,
CID6215,
ydroxyprednisolone 16,17-acetonide,
AN-252,
AR-1H0758,
C24-H30-F2-O6,
CS-O-01517,
Fluocinolone acetonide (JP15/USP/INN),
6.Alpha., 9.alpha.-Difluoro-16.alpha.-h,
B2095,
D005446,
6.alpha.,9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide,
FS,
6.alpha.,9-Difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,
959-32-0,
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-,
Pregna-1,4-diene-3,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone,
|
| Complexity | 960 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 9 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 452.201g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 32 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 452.495g/mol |
| Monoisotopic Mass | 452.201g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 93.1A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.5 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P305+P351+P338-P261-P280a-P304+P340-P405-P501a |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

